CN1552333A - Medicine for preventing depression - Google Patents
Medicine for preventing depression Download PDFInfo
- Publication number
- CN1552333A CN1552333A CNA031122221A CN03112222A CN1552333A CN 1552333 A CN1552333 A CN 1552333A CN A031122221 A CNA031122221 A CN A031122221A CN 03112222 A CN03112222 A CN 03112222A CN 1552333 A CN1552333 A CN 1552333A
- Authority
- CN
- China
- Prior art keywords
- extract accounts
- medicine
- hypochondriacal
- control
- components
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine for treating melancholia is prepared from 3 Chinese-medicinal materials including forsythia fruit, ginseng, etc through extracting, proportional mixing, pulverizing, sieving and granulating. Its advantages are high curative effect and quickly taking its effect.
Description
Affiliated technical field
The present invention relates to a kind of hypochondriacal medicine that prevents and treat, particularly a kind of is the hypochondriacal Chinese medicine preparation of a kind of control of raw material with the vegetable Chinese herbal medicine extract.
Background technology
The Herba Hyperici perforati effective ingredient is a hypericin, is one of at present most popular medical herbs in the whole world, is better than Western medicine for light to moderate hypochondriacal therapeutic effect, and is very effective for hypochondriacal treatment, now has been applied to clinical.
The main chemical compositions of Radix Ginseng is a Radix Ginseng soap two, has strengthening by means of tonics, nourishes blood and give birth to the function of rule, the mind calming and mentality promoting, and it has regulating action to immune system, and the central nervous system is had protective effect.
Slips is a kind of Piper plant that is grown in flat island, South Pacific, and it contains kavalactones, and medicine clinical research finds that kavalactones can obviously alleviate three big human health obstacle---anxiety, melancholy and insomnias.
More than three kinds of medicines all have the hypochondriacal effect of control, but also do not have use in conjunction.
Summary of the invention
Purpose of the present invention overcomes above-mentioned deficiency exactly, and provides a kind of with these three kinds of medication combined application, the control melancholia, and than single medicine good effect, the pharmaceutical composition that effect is fast.
The melancholia is a kind of disease that influences human health, and sickness rate increases gradually in recent years, and the harm that brings to society is very big.Therefore, research prevention and treatment melancholia medicine become the current research emphasis.In recent years, Chinese medicine has been obtained certain progress having carried out series of experiment research and clinical application research aspect this disease of control, has shown the advantage of Chinese medicine.
Solution of the present invention is to be based upon Chinese medicine on the pathogenetic basis that studies for a long period of time of melancholia, achieve with reference to modern pharmacological research, filter out effective 3 kinds of drug regimens to the control melancholia from plant class Chinese herbal medicine, the melancholia has obtained better curative effect to control.
The hypochondriacal medicine of this kind control, be made up of following components in weight percentage: the slips extract accounts for 1-60%, and Herba Hyperici perforati extract accounts for 1-60%, and Radix Ginseng extract accounts for 1-40%;
Sieve is thoroughly mixed, pulverized to said components, and Chinese medicine preparation is made in pelletize.
Its further component is: the slips extract accounts for 20-50%, and Herba Hyperici perforati extract accounts for 20-50%, and Radix Ginseng extract accounts for 10-30%.
Described preparation is capsule or electuary.
Its capsular compound method is to get the slips extract by prescription, after Herba Hyperici perforati extract, Radix Ginseng extract, mixed powder are broken to 80-100 order granularity, and pelletize, encapsulated.Every heavy 500mg, day clothes 3 times, each 1.
The preparation method those skilled in the art of electuary are easy to preparation by said method.
This medicine dropped into clinical trial in 2000, and patient's popular welcome now discloses following case and describes: control melancholia clinical case, select the melancholiac among in October, 2000-calendar year 2001 December outpatient service and the inpatient, totally 120 examples, all cases all meet the Chinese and western medicine diagnostic criteria, the patient takes 1 of this medicine at every turn, every day 1 time, observed 56 examples of fully recovering 3 months, produce effects 26 examples, effective 10 examples, invalid 28 examples, total effective rate is 76.7%.Therefore, the present invention prevents and treats the melancholia, and than single medicine good effect, effect is fast.Its creativeness is conspicuous.
The specific embodiment
Example 1, the hypochondriacal medicine of a kind of control (double centner), form (kilogram) by weight components: the slips extract accounts for 1, and Herba Hyperici perforati extract accounts for 60, and Radix Ginseng extract accounts for 39; Said components is mixed, pulverized saturating 100 mesh sieves, and pelletize incapsulates, every heavy 500mg.
Example 2, the hypochondriacal medicine of a kind of control (double centner), form (kilogram) by weight components: the slips extract accounts for 1, and Herba Hyperici perforati extract accounts for 59, and Radix Ginseng extract accounts for 40; Said components is mixed, pulverized saturating 100 mesh sieves, and pelletize incapsulates, every heavy 500mg.
Example 3, the hypochondriacal medicine of a kind of control (double centner), form (kilogram) by weight components: the slips extract accounts for 30, and Herba Hyperici perforati extract accounts for 60, and Radix Ginseng extract accounts for 10; Said components is mixed, pulverized saturating 100 mesh sieves, and pelletize incapsulates, every heavy 500mg.
Example 4, the hypochondriacal medicine of a kind of control (double centner), form (kilogram) by weight components: the slips extract accounts for 30, and Herba Hyperici perforati extract accounts for 30, and Radix Ginseng extract accounts for 40; Said components is mixed, pulverized saturating 100 mesh sieves, and pelletize incapsulates, every heavy 500mg.
Example 5, the hypochondriacal medicine of a kind of control (double centner), form (kilogram) by weight components: the slips extract accounts for 60, and Herba Hyperici perforati extract accounts for 1, and Radix Ginseng extract accounts for 39; Said components is mixed, pulverized saturating 100 mesh sieves, and pelletize incapsulates, every heavy 500mg.
Example 6, the hypochondriacal medicine of a kind of control (double centner), form (kilogram) by weight components: the slips extract accounts for 60, and Herba Hyperici perforati extract accounts for 30, and Radix Ginseng extract accounts for 10; Said components is mixed, pulverized saturating 100 mesh sieves, and pelletize incapsulates, every heavy 500mg.
Example 7, the hypochondriacal medicine of a kind of control (double centner), form (kilogram) by weight components: the slips extract accounts for 20, and Herba Hyperici perforati extract accounts for 60, and Radix Ginseng extract accounts for 20; Said components is mixed, pulverized saturating 100 mesh sieves, and pelletize incapsulates, every heavy 500mg.
Example 8, the hypochondriacal medicine of a kind of control (double centner), form (kilogram) by weight components: the slips extract accounts for 60, and Herba Hyperici perforati extract accounts for 39, and Radix Ginseng extract accounts for 1; Said components is mixed, pulverized saturating 100 mesh sieves, and pelletize incapsulates, every heavy 500mg.
Example 9, the hypochondriacal medicine of a kind of control (double centner), form (kilogram) by weight components: the slips extract accounts for 39, and Herba Hyperici perforati extract accounts for 60, and Radix Ginseng extract accounts for 1; Said components is mixed, pulverized saturating 100 mesh sieves, and pelletize incapsulates, every heavy 500mg.
Example 10, the hypochondriacal medicine of a kind of control (double centner), form (kilogram) by weight components: the slips extract accounts for 20, and Herba Hyperici perforati extract accounts for 50, and Radix Ginseng extract accounts for 30; Said components is mixed, pulverized saturating 100 mesh sieves, and pelletize incapsulates, every heavy 500mg.
Example 11, the hypochondriacal medicine of a kind of control (double centner), form (kilogram) by weight components: the slips extract accounts for 50, and Herba Hyperici perforati extract accounts for 20, and Radix Ginseng extract accounts for 30; Said components is mixed, pulverized saturating 100 mesh sieves, and pelletize incapsulates, every heavy 500mg.
Example 12, the hypochondriacal medicine of a kind of control (double centner), form (kilogram) by weight components: the slips extract accounts for 50, and Herba Hyperici perforati extract accounts for 40, and Radix Ginseng extract accounts for 10; Said components is mixed, pulverized saturating 100 mesh sieves, and pelletize incapsulates, every heavy 500mg.
Claims (3)
1, the hypochondriacal medicine of a kind of control, it is characterized in that being made up of following components in weight percentage: the slips extract accounts for 1-60%, and Herba Hyperici perforati extract accounts for 1-60%, and Radix Ginseng extract accounts for 1-40%;
Sieve is thoroughly mixed, pulverized to said components, and Chinese medicine preparation is made in pelletize.
2, the hypochondriacal medicine of a kind of control according to claim 1, it is characterized in that described component is: the slips extract accounts for 20-50%, and Herba Hyperici perforati extract accounts for 20-50%, and Radix Ginseng extract accounts for 10-30%.
3, the hypochondriacal medicine of a kind of control according to claim 1 is characterized in that described preparation is a capsule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA031122221A CN1552333A (en) | 2003-06-03 | 2003-06-03 | Medicine for preventing depression |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA031122221A CN1552333A (en) | 2003-06-03 | 2003-06-03 | Medicine for preventing depression |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1552333A true CN1552333A (en) | 2004-12-08 |
Family
ID=34319898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA031122221A Pending CN1552333A (en) | 2003-06-03 | 2003-06-03 | Medicine for preventing depression |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1552333A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2110135A3 (en) * | 2005-03-25 | 2010-12-22 | Beijing Wonner Biotech Ltd. Co. | A pharmaceutical composition for treating depression and method for preparation thereof |
CN101816766B (en) * | 2010-01-27 | 2011-05-04 | 湖南时代阳光药业股份有限公司 | Chinese medicinal composition for treating tristimania |
CN102961452A (en) * | 2012-11-23 | 2013-03-13 | 西安泰科迈医药科技有限公司 | Medicinal composition for relieving depression and preparation method thereof |
-
2003
- 2003-06-03 CN CNA031122221A patent/CN1552333A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2110135A3 (en) * | 2005-03-25 | 2010-12-22 | Beijing Wonner Biotech Ltd. Co. | A pharmaceutical composition for treating depression and method for preparation thereof |
CN101816766B (en) * | 2010-01-27 | 2011-05-04 | 湖南时代阳光药业股份有限公司 | Chinese medicinal composition for treating tristimania |
CN102961452A (en) * | 2012-11-23 | 2013-03-13 | 西安泰科迈医药科技有限公司 | Medicinal composition for relieving depression and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1552333A (en) | Medicine for preventing depression | |
CN1304769A (en) | Blood-cleaning pill | |
CN1194724C (en) | Chinese medical preparation for treating coronary disease and angina pectoris and preparation thereof | |
CN1611232A (en) | Medicinal composition with main effect of antifatigue, radioresistance and melancholia-resistance and its preparing method | |
CN1246007C (en) | Medicine for preventing cold | |
CN103054952A (en) | Medicine for treating periodontitis and preparation method thereof | |
CN1297765A (en) | Tibetans medicine for treating cardiac and cerebral vascular disease and white pulse disease | |
CN1846744A (en) | Chinese medicine for treating acute and chronic appendicitis | |
CN1164294C (en) | Liver cancer resisting medicine | |
CN1552338A (en) | Medicine for preventing cardiovascular disease | |
CN1768803A (en) | Medicine for treating hypertension and its preparing process | |
CN1129447C (en) | Anshen pill-treating cardio-cerebral angiopathy | |
CN1488382A (en) | Health-care medicine for preventing and curing cardio-cerebrovascular diseae | |
CN1059120C (en) | Chinese medicine for treating bone wound | |
CN1194716C (en) | Chinese patent drug made by using pseudo-ginseng and epimedium as raw material for curing coronary heart disease | |
CN1552340A (en) | Medicine for preventing nephroma | |
CN1181859C (en) | Capsule for protrusion of vertebral disc and its preparation | |
CN1552341A (en) | Medicine for preventing diabets mellitus | |
CN1272060C (en) | Medicine for preventing apoplexy and its preparation method | |
CN1552342A (en) | Medicine for preventing gynaecological disease | |
CN1051934C (en) | Xiansukang capsule for curing epilepsy and its production | |
CN1552336A (en) | Medicine for preventing prostatic disorders | |
CN1552435A (en) | Medicine for preventing tumour | |
CN1381258A (en) | Xinnaoshutong ketone and its preparing process | |
CN1232292C (en) | Chinese medicine for treating prostatitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |